These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37995512)

  • 1. Extracellular contrast agent-enhanced MRI is as effective as gadoxetate disodium-enhanced MRI for predicting microvascular invasion in HCC.
    Sheng L; Wei H; Yang T; Yang J; Zhang L; Zhu X; Jiang H; Song B
    Eur J Radiol; 2024 Jan; 170():111200. PubMed ID: 37995512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI.
    Jiang H; Wei J; Fu F; Wei H; Qin Y; Duan T; Chen W; Xie K; Lee JM; Bashir MR; Wang M; Song B; Tian J
    Liver Int; 2022 May; 42(5):1158-1172. PubMed ID: 35243749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy.
    Yan M; Zhang X; Zhang B; Geng Z; Xie C; Yang W; Zhang S; Qi Z; Lin T; Ke Q; Li X; Wang S; Quan X
    Eur Radiol; 2023 Jul; 33(7):4949-4961. PubMed ID: 36786905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: An intra-individual comparative study based on the Liver Imaging Reporting and Data System.
    Yang J; Jiang H; Xie K; Bashir MR; Wan H; Huang J; Qin Y; Chen J; Lu Q; Song B
    Eur J Radiol; 2022 Sep; 154():110397. PubMed ID: 35696735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of non-radiomics imaging features and radiomics models based on contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma within 5 cm.
    Zheng R; Zhang X; Liu B; Zhang Y; Shen H; Xie X; Li S; Huang G
    Eur Radiol; 2023 Sep; 33(9):6462-6472. PubMed ID: 37338553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
    Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
    World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
    Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
    Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging.
    Chen Y; Qin Y; Wu Y; Wei H; Wei Y; Zhang Z; Duan T; Jiang H; Song B
    Front Immunol; 2022; 13():973153. PubMed ID: 36091074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm.
    Chong HH; Yang L; Sheng RF; Yu YL; Wu DJ; Rao SX; Yang C; Zeng MS
    Eur Radiol; 2021 Jul; 31(7):4824-4838. PubMed ID: 33447861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria.
    Ryu T; Takami Y; Wada Y; Tateishi M; Hara T; Yoshitomi M; Momosaki S; Yasumori K; Saitsu H; Okuda K
    J Gastrointest Surg; 2019 Apr; 23(4):779-787. PubMed ID: 30788712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
    Feng ST; Jia Y; Liao B; Huang B; Zhou Q; Li X; Wei K; Chen L; Li B; Wang W; Chen S; He X; Wang H; Peng S; Chen ZB; Tang M; Chen Z; Hou Y; Peng Z; Kuang M
    Eur Radiol; 2019 Sep; 29(9):4648-4659. PubMed ID: 30689032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC.
    Jiang H; Wei H; Yang T; Qin Y; Wu Y; Chen W; Shi Y; Ronot M; Bashir MR; Song B
    Radiology; 2023 Apr; 307(2):e221835. PubMed ID: 36786702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.
    Wei H; Jiang H; Qin Y; Wu Y; Lee JM; Yuan F; Zheng T; Duan T; Zhang Z; Qu Y; Chen J; Chen Y; Ye Z; Yao S; Zhang L; Yang T; Song B
    Eur Radiol; 2022 Nov; 32(11):7578-7589. PubMed ID: 35554652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Gadoxetic Acid-Enhanced MRI Features for Evaluation of Vessels Encapsulating Tumor Clusters and Microvascular Invasion in Hepatocellular Carcinoma: Creating Nomograms for Risk Assessment.
    Qu Q; Liu Z; Lu M; Xu L; Zhang J; Liu M; Jiang J; Gu C; Ma Q; Huang A; Zhang X; Zhang T
    J Magn Reson Imaging; 2024 Sep; 60(3):1094-1110. PubMed ID: 38116997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinoma.
    Wu CH; Lee YH; Liang PC; Hu RH; Shih TT; Ho MC
    J Formos Med Assoc; 2022 Aug; 121(8):1550-1559. PubMed ID: 35033411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
    Cha DI; Kang TW; Jeong WK; Kim JM; Choi GS; Joh JW; Yi NJ; Ahn SH
    Eur Radiol; 2024 Jan; 34(1):498-508. PubMed ID: 37505248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and Prognostication of Gd-EOB-DTPA MRI and CT in Patients With Macrotrabecular-Massive Hepatocellular Carcinoma.
    Cheng J; Li X; Wang L; Chen F; Li Y; Zuo G; Pei M; Zhang H; Yu L; Liu C; Wang J; Han Q; Cai P; Li X
    J Magn Reson Imaging; 2024 Jun; 59(6):2071-2081. PubMed ID: 37840197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators.
    Zhang K; Xie SS; Li WC; Ye ZX; Shen ZW; Shen W
    Eur Radiol; 2022 Jun; 32(6):4186-4197. PubMed ID: 35048134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular invasion-negative hepatocellular carcinoma: Prognostic value of qualitative and quantitative Gd-EOB-DTPA MRI analysis.
    Wang L; Liang M; Feng B; Li D; Cong R; Chen Z; Wang S; Ma X; Zhao X
    Eur J Radiol; 2023 Nov; 168():111146. PubMed ID: 37832198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual comparison of prognostic imaging features of HCCs between MRIs with extracellular and hepatobiliary contrast agents.
    Yoon JK; Han DH; Lee S; Choi JY; Choi GH; Kim DY; Kim MJ
    Liver Int; 2024 Oct; 44(10):2847-2857. PubMed ID: 39105495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.